Monday, August 15, 2022



Contact us 561.316.3330

Doug Sweeny Is Hired Chief Business Officer at Prenuvo

To Lead Marketing, Sales and Product

Doug Sweeny has joined the team at Prenuvo as Chief Business Officer.

Doug Sweeny will be responsible for sales, marketing, and product functions. He will join the leadership team, be a board observer, and report to Founder & CEO Andrew Lacy.

“Doug Sweeny brings a wealth of experience building iconic, mission-driven global brands across a variety of business categories to Prenuvo. His approach to strengthening consumers’ connection to beloved brands will have a deep impact on Prenuvo as we grow,” said Andrew Lacy, Founder & CEO.

“I’m thrilled to be joining the Prenuvo team and help change lives in a meaningful way. More than ever, consumers are hungry for deeper insights into their health and Prenuvo allows them to move into the driver’s seat like never before. Prenuvo’s technology and AI give consumers the ‘superpower’ to understand what is happening inside their body,” said Doug Sweeny.

Doug is an accomplished marketing and growth executive with deep experience leading both consumer and business-to-business global brands. Before Prenuvo, Doug was Chief Marketing Officer at One Medical leading marketing, growth, creative, B2B and PR. He led this function through transformational growth for One Medical from a private to a public company and led the COVID-19 response with the mayor’s offices in NYC and San Francisco.

Prior to One Medical, Doug was the Vice President of Marketing at Google’s Nest and led marketing from start-up phase through Google $3.2B acquisition and integration. Before Nest, Doug Sweeny was the Vice President of Levi’s Global Marketing.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Subscribe to Medical Device News Magazine

Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

"These data demonstrate that the Hemopurifier can effectively capture a wide range of clinically relevant SARS-CoV-2 variants," said Charles J. Fisher, M.D., Chief Executive Officer of Aethlon Medical.

Adagio Medical Announces Publication of Cryocure-2 Data

"The publication of Cryocure-2 data is seen as a significant step in the validation of Adagio's ULTC technology," said Olav Bergheim, President and CEO of Adagio Medical.

Artivion Initiates Enrollment in PERSEVERE Clinical Trial

Artivion advises the trial is designed to support the company's forthcoming application to the U.S. Food and Drug Administration for premarket approval of the AMDS.

By using this website you agree to accept Medical Device News Magazine Privacy Policy